http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2254995-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba045776bcd32d32e3100da8dfce4e28 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate | 1997-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f87757d215559e59866412eeb9c52fe |
publicationDate | 1997-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2254995-A1 |
titleOfInvention | Cell adhesion inhibiting compounds |
abstract | Cyclic peptide of formula (I) where Xaa1 is selected from L-amino acids selected from Phe, Lys and Arg; D-amino acids selected from Phe and Met, the L-and D-amino acid optionally substituted on its .alpha.-carbon or its .alpha.-amino group with a C1-4 alkyl group; and MeIle; Xaa2, Xaa3 et Xaa4 are respectively Leu, Asp and Val, optionally substituted on their .alpha.-carbon or .alpha.-amino group with a C1-4 alkyl group; X1 is selected from D-amino acids selected from Ala, Phe, Arg, Lys, Trp, hArg(Et)2, Orn(CHMe2), Orn(Me2), Lys(CHMe2) and Arg(Pmc), optionally substituted on their .alpha.-carbon or .alpha.-amino group with a C1-4 alkyl group; Formula (II); NH(CH2)5CO; and NH(CH2)2S(CH2)yCO, where y is 1 or 2; X2 is selected from D-amino acids selected from Ala, Arg, Lys, His, hArg(Et)2, Orn(CHMe2), and Orn(Me2), optionally substituted on their .alpha.-carbon or .alpha.-amino group with a C1-4 alkyl group; NH(CH2)2SCH2CO; and NH(CH2)xCO, where x is 2 or 3; Xaa5 and Xaa6 are each independently a D-amino acid selected from Ala and Arg, optionally substituted on its .alpha.-carbon or .alpha.-amino group with a C1-4 alkyl group; p is 0 or 1; and q is 0 or when p is 1, q is 0 or 1; or a salt thereof. The cyclic peptides inhibit the interaction of vascular cell adhesion molecule-1 and fibronectin with integrin very late antigen 4 (.alpha.4.beta.1) and of mucosal addressin cell adhesion molecule -1 (MAdCAM-1) with integrin .alpha.4.beta.7. They have therapeutic applications such as in rheumatoid arthritis, multiple sclerosis, asthma, psoriasis, inflammatory bowel disease and insulin-dependent diabetes. |
priorityDate | 1996-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 452.